ATE335495T1 - Pharmazeutische zubereitung enthaltend poröse sphärische kohlenstoffhaltige teilchen und deren verwendung zur behandlung von leber- und nierenerkrankungen - Google Patents

Pharmazeutische zubereitung enthaltend poröse sphärische kohlenstoffhaltige teilchen und deren verwendung zur behandlung von leber- und nierenerkrankungen

Info

Publication number
ATE335495T1
ATE335495T1 AT02022633T AT02022633T ATE335495T1 AT E335495 T1 ATE335495 T1 AT E335495T1 AT 02022633 T AT02022633 T AT 02022633T AT 02022633 T AT02022633 T AT 02022633T AT E335495 T1 ATE335495 T1 AT E335495T1
Authority
AT
Austria
Prior art keywords
porous spherical
liver
treatment
pharmaceutical preparation
carbon particles
Prior art date
Application number
AT02022633T
Other languages
English (en)
Inventor
Hideyuki Yamato
Satoshi Mitsuhashi
Michihito Ise
Haruhisa Hayashi
Original Assignee
Kureha Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kureha Corp filed Critical Kureha Corp
Application granted granted Critical
Publication of ATE335495T1 publication Critical patent/ATE335495T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AT02022633T 2002-10-09 2002-10-09 Pharmazeutische zubereitung enthaltend poröse sphärische kohlenstoffhaltige teilchen und deren verwendung zur behandlung von leber- und nierenerkrankungen ATE335495T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02022633A EP1407772B9 (de) 2002-10-09 2002-10-09 Pharmazeutische Zubereitung enthaltend poröse sphärische kohlenstoffhaltige Teilchen und deren Verwendung zur Behandlung von Leber- und Nierenerkrankungen

Publications (1)

Publication Number Publication Date
ATE335495T1 true ATE335495T1 (de) 2006-09-15

Family

ID=32010951

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02022633T ATE335495T1 (de) 2002-10-09 2002-10-09 Pharmazeutische zubereitung enthaltend poröse sphärische kohlenstoffhaltige teilchen und deren verwendung zur behandlung von leber- und nierenerkrankungen

Country Status (5)

Country Link
EP (1) EP1407772B9 (de)
AT (1) ATE335495T1 (de)
DE (1) DE60213819T2 (de)
DK (1) DK1407772T3 (de)
ES (1) ES2269580T3 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI370012B (en) * 2004-04-02 2012-08-11 Kureha Corp Adsorbent for oral administration, and agent for treating or preventing renal or liver disease
TWI370013B (en) * 2004-04-02 2012-08-11 Kureha Corp Adsorbent for oral administration, and agent for treating or preventing renal or liver disease
GB201204696D0 (en) 2012-03-16 2012-05-02 Ucl Business Plc Therapy

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS565313A (en) * 1979-06-26 1981-01-20 Kureha Chem Ind Co Ltd Detoxificating spherical active carbon and preparing the same
US4761284A (en) * 1977-12-27 1988-08-02 Kureha Kagaku Kogy Kabushiki Kaisha Antidote including activated carbon particles
JPS5673542A (en) * 1979-11-22 1981-06-18 Kureha Chem Ind Co Ltd Adsorbent
JP3518878B2 (ja) * 1992-10-29 2004-04-12 呉羽化学工業株式会社 抗ネフローゼ症候群剤
CA2162086A1 (en) * 1994-11-15 1996-05-16 Michihito Ise Agent for reducing nephrotoxicity due to medicine
JP3522708B2 (ja) * 2001-04-11 2004-04-26 呉羽化学工業株式会社 経口投与用吸着剤

Also Published As

Publication number Publication date
DK1407772T3 (da) 2006-12-11
EP1407772B9 (de) 2007-02-21
EP1407772B1 (de) 2006-08-09
DE60213819D1 (de) 2006-09-21
EP1407772A1 (de) 2004-04-14
ES2269580T3 (es) 2007-04-01
DE60213819T2 (de) 2007-08-09

Similar Documents

Publication Publication Date Title
ATE365558T1 (de) Adsorptionsmittel in oraler darreichungsform
Zare et al. Remediation of pharmaceuticals from contaminated water by molecularly imprinted polymers: a review
ATE388716T1 (de) Absorbens zur oralen aufnahme, und mittel zur behandlung oder vorbeugung von nieren- oder lebererkrankungen
CA2111398A1 (en) Upset resistant macroporous carbon-inorganic oxide composite support for bioremediation
CA2504517A1 (en) Adsorbent for oral administration, and agent for treating or preventing renal or liver disease
RU2006138608A (ru) Адсорбент для перорального введения и средство для лечения или профилактики заболевания почек или печени
EP0740650A4 (de) Kombinierte wirkstoffe als methode zur gezielten wirkstoff-freisetzung
CA2343123A1 (en) Active substance concentrate with formoterol, suitable for storage
FR2780052B1 (fr) Agglomerats a base de charbon actif leur procede de preparation et leur utilisation comme agents d'adsorption
CN107953424A (zh) 一种具有甲醛净化功能的木质材料及其制备方法
CN103025316A (zh) 硅藻土在医药工业中的用途
DE60213819D1 (de) Pharmazeutische Zubereitung enthaltend poröse sphärische kohlenstoffhaltige Teilchen und deren Verwendung zur Behandlung von Leber- und Nierenerkrankungen
ATE405278T1 (de) Adsorbentien zur oralen verabreichung
HU201138B (en) Device for filtering the respiratory air with chemisorption filter
KR950031090A (ko) 치질 치료용 약제학적 조성물
JPH09308813A (ja) カセット式空気浄化フィルタ及び脱臭装置
JP2000041670A (ja) 脱臭システムおよび脱臭装置
WO2002080885B1 (en) Detoxification and decontamination using nanotechnology therapy
JPS62178642A (ja) 建材
TW200500084A (en) Adsorbent for oral administration and pharmaceutical composition, and method of manufacturing absorbent for oral administration
JPS63274434A (ja) 脱臭方法
JP4827384B2 (ja) 生体の過酸化脂質の生成抑制用の浄化剤
CN100357364C (zh) 具空气净化功能的多层复合型纳米涂层材料及用途
WO2003024568A3 (en) Air purifying procedure and saline material of spongy structure
CN109794218A (zh) 复合空气净化剂及其制备方法

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1407772

Country of ref document: EP